Related Experiment Video
Updated: Jul 24, 2025

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network
Christina B Ching1, Kimberley Dickinson2, John Karafilidis3
1Department of Pediatric Urology, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. christina.ching@nationwidechildrens.org.
Insights
Primary hyperoxaluria (PH) in children requires significant healthcare, often involving kidney stones and transplants. Improved multidisciplinary specialist involvement could enhance diagnosis and treatment for PH patients.
Area of Science:
- Pediatric Nephrology
- Rare Diseases
- Health Services Research
Background:
- Primary hyperoxaluria (PH) is a rare metabolic disorder with significant renal and extra-renal implications.
- Understanding the clinical care pathways and health service utilization in pediatric PH is crucial for improving patient outcomes.
- Existing studies often focus on clinical manifestations or registries, with less emphasis on the comprehensive care journey.
Purpose of the Study:
- To describe the clinical care course and health service utilization in a United States cohort of pediatric patients with primary hyperoxaluria (PH).
- To identify patterns in diagnostic testing, interventions, and specialty care involvement for PH patients.
- To highlight areas for improvement in the multidisciplinary management of pediatric PH.
Main Methods:
- Retrospective cohort study of pediatric PH patients (<18 years) within the PEDSnet clinical research network (2009-2021).
- Outcomes included diagnostic imaging, PH-specific interventions, and hospital service utilization, analyzed relative to cohort entrance date (CED).
- Analysis of patient demographics, PH types (1, 2, 3), and follow-up duration.
Main Results:
- Thirty-three pediatric PH patients were identified (23 PH type 1, 4 PH type 2, 6 PH type 3), with a median age of 5.0 years at CED.
- High healthcare utilization observed, with 82% undergoing imaging for kidney stones and 46% requiring stone surgery.
- Twelve percent needed dialysis (prior to CED) and 12% required renal or renal/liver transplant; multidisciplinary specialist involvement was limited (12%-36%).
Conclusions:
- Pediatric PH patients in the U.S. experience substantial healthcare utilization, including significant renal interventions.
- There are opportunities to enhance care by increasing the involvement of multidisciplinary specialists in PH management.
- Optimizing specialty care coordination can potentially improve diagnosis, treatment, and prevention of PH complications.
Abstract:
The rarity of primary hyperoxaluria (PH) challenges our understanding of the disease. The purpose of our study was to describe the course of clinical care in a United States cohort of PH pediatric patients, highlighting health service utilization. We performed a retrospective cohort study of PH patients < 18 years old in the PEDSnet clinical research network from 2009 to 2021. Outcomes queried included diagnostic imaging and testing related to known organ involvement of PH, surgical and medical interventions specific to PH-related renal disease, and select PH-related hospital service utilization. Outcomes were evaluated relative to cohort entrance date (CED), defined as date of first PH-related diagnostic code. Thirty-three patients were identified: 23 with PH type 1; 4 with PH type 2; 6 with PH type 3. Median age at CED was 5.0 years (IQR 1.4, 9.3 years) with the majority being non-Hispanic white (73%) males (70%). Median follow-up between CED and most recent encounter was 5.1 years (IQR 1.2, 6.8). Nephrology and Urology were the most common specialties involved in care, with low utilization of other sub-specialties (12%-36%). Most patients (82%) had diagnostic imaging used to evaluate kidney stones; 11 (33%) had studies of extra-renal involvement. Stone surgery was performed in 15 (46%) patients. Four patients (12%) required dialysis, begun in all prior to CED; four patients required renal or renal/liver transplant. Conclusion: In this large cohort of U.S. PH children, patients required heavy health care utilization with room for improvement in involving multi-disciplinary specialists. What is Known: • Primary hyperoxaluria (PH) is rare with significant implications on patient health. Typical involvement includes the kidneys; however, extra-renal manifestations occur. • Most large population studies describe clinical manifestations and involve registries. What is New: • We report the clinical journey, particularly related to diagnostic studies, interventions, multispecialty involvement, and hospital utilization, of a large cohort of PH pediatric patients in the PEDSnet clinical research network. • There are missed opportunities, particularly in that of specialty care, that could help in the diagnosis, treatment, and even prevention of known clinical manifestations.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Related Concept Videos
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis I: Introduction